Prosus NV (PRX.AS)

Close: 39.98 (+0.05), Apr 24, 2025
Hold

Medium risk

Automatic technical analysis. Medium term, Apr 24, 2025

Investors have paid higher prices over time to buy Prosus NV and the stock is in a rising trend channel in the medium long term. Rising trends indicate that the company experiences positive development and that buy interest among investors is increasing. The price has had a strong fall after the negative signal from the rectangle formation at the break down through the support at 42.82. The objective at 40.05 is now met, but the formation signals further development in the same direction. The stock is approacing resistance at 41.30 euro, which may give a negative reaction. However, a break upwards through 41.30 euro will be a positive signal. Negative volume balance indicates that volume is high on days with falling prices and low on days with rising prices, which weakens the stock. The stock is overall assessed as technically neutral for the medium long term.

Recommendation one to six months: Hold (Score: -18)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.42%87.38+0.14%
5 days10.464.89%122.32+4.93%
22 days-64.7314.05%156.98-7.97%
66 days-37.0226.77%166.07+13.68%

More analyses of Prosus NV

chart Prosus NV (PRX) Candlesticks 22 Days
Candlesticks
chart Prosus NV (PRX) Short term
Short term: Weak Negative
chart Prosus NV (PRX) Medium term
Medium term: Hold
chart Prosus NV (PRX) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.